SAN DIEGO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- MyEZSmokes Inc. (Pink Sheets:XRMB) announced that the Company has entered into an agreement to access up to $1M through a stock based equity offering for the primary purpose of advancement of its market presence.
CEO, Dan Balsiger noted "We are pleased to have had our 1-A registration statement cleared by the SEC so that we can begin to access the additional funds needed to advance our product marketing efforts. As recently reported in a Wall Street Journal article, we expect this current $1B marketplace to grow substantially to a $10B presence over the next five years and are working to position our product line to achieve a top ten presence within our peer group during this exciting emerging growth period."
Mr. Balsiger further stated that "We are developing and are in the process of implementing a new web presence that will be coupled with a unique distribution partner network opportunity that offers a substantial profit proposition we believe will significantly drive the sales of our product over the next several years through a network marketing presence. Our general goal of becoming one of the top ten in this product channel should allow us to achieve a healthy profit while providing a good return to our shareholders."
About MyEZsmokes Inc. (www.myezsmokes.com)
Headquartered in San Diego, California, MyEZsmokes Inc. engages in the manufacture and distribution of electronic cigarettes. The company offers disposable and starter kits e-cigarettes as well as cartomizers in tobacco and menthol flavors. For further information please contact the Company at:
(Investor Relations 858.509.2783 or Sales@myezsmokes.com)
Safe Harbor Statement
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTCBB website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements. Additionally, the 1-A registration statement will generate additional free trading shares to the marketplace at a pre-determined price which may impact our share pricing within the OTC marketplace in a manner that we cannot predict.